Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
McMaster University launches first online interactive educational program on bleeding disorders

McMaster University launches first online interactive educational program on bleeding disorders

Specialty pharmaceutical market: Treatment patterns and product performance

Specialty pharmaceutical market: Treatment patterns and product performance

Amber Pharmacy receives ACHC accreditation

Amber Pharmacy receives ACHC accreditation

NHLBI awards new federal grant to improve the quality of stored transfusion blood

NHLBI awards new federal grant to improve the quality of stored transfusion blood

Wyeth pledges more than 40 million IUs of factor concentrates to WFH

Wyeth pledges more than 40 million IUs of factor concentrates to WFH

NHLBI awards stimulus funds for hemophilia drug research

NHLBI awards stimulus funds for hemophilia drug research

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

Canadians with hemophilia A can use new treatment option, XYNTHA

Canadians with hemophilia A can use new treatment option, XYNTHA

Therapeutic agents in soy can treat colon cancer, says study

Therapeutic agents in soy can treat colon cancer, says study

Lysteda tablets to treat menorrhagia approved by the FDA

Lysteda tablets to treat menorrhagia approved by the FDA

Amsterdam Molecular Therapeutics provides third-quarter 2009 business updates

Amsterdam Molecular Therapeutics provides third-quarter 2009 business updates

Lack of hemophilia treatment in the developing world costing lives

Lack of hemophilia treatment in the developing world costing lives

Baxter International lauds new Medicare education benefit for chronic kidney disease patients

Baxter International lauds new Medicare education benefit for chronic kidney disease patients

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

C1-INH concentrate, an effective therapy to treat acute swelling attacks for HAE

C1-INH concentrate, an effective therapy to treat acute swelling attacks for HAE

GTC Biotherapeutics announces financial results for third quarter 2009

GTC Biotherapeutics announces financial results for third quarter 2009

Gene therapy saves two children with adrenoleukodystrophy

Gene therapy saves two children with adrenoleukodystrophy

LFB Biotechnologies exercises its option to purchase $12.8 million of stocks in GTC Biotherapeutics

LFB Biotechnologies exercises its option to purchase $12.8 million of stocks in GTC Biotherapeutics

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

NYBC and its divisions call upon the community to join the fight against cancer by donating blood

NYBC and its divisions call upon the community to join the fight against cancer by donating blood